Подписаться
Simo Näkki
Simo Näkki
Medical physicist, Seinäjoki Central hospital
Нет подтвержденного адреса электронной почты
Название
Процитировано
Процитировано
Год
Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
S Näkki, J Rytkönen, T Nissinen, C Florea, J Riikonen, P Ek, H Zhang, ...
Acta biomaterialia 13, 207-215, 2015
732015
Chlorin e6 functionalized theranostic multistage nanovectors transported by stem cells for effective photodynamic therapy
S Nakki, JO Martinez, M Evangelopoulos, W Xu, VP Lehto, E Tasciotti
ACS applied materials & interfaces 9 (28), 23441-23449, 2017
602017
Tailored dual PEGylation of inorganic porous nanocarriers for extremely long blood circulation in vivo
T Nissinen, S Nakki, H Laakso, D Kuciauskas, A Kaupinis, MI Kettunen, ...
ACS applied materials & interfaces 8 (48), 32723-32731, 2016
482016
Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ...
Biomaterials 52, 44-55, 2015
472015
Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles
K Tamarov, S Näkki, W Xu, VP Lehto
Journal of Materials Chemistry B 6 (22), 3632-3649, 2018
432018
Facile synthesis of biocompatible superparamagnetic mesoporous nanoparticles for imageable drug delivery
T Nissinen, S Näkki, M Latikka, M Heinonen, T Liimatainen, W Xu, ...
Microporous and mesoporous materials 195, 2-8, 2014
162014
Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
D Lumen, S Näkki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ...
Pharmaceutics 11 (12), 686, 2019
142019
Designed inorganic porous nanovector with controlled release and MRI features for safe administration of doxorubicin
S Näkki, JTW Wang, J Wu, L Fan, J Rantanen, T Nissinen, MI Kettunen, ...
International journal of pharmaceutics 554, 327-336, 2019
142019
Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis
R Thapa, S Mondal, J Riikonen, J Rantanen, S Näkki, T Nissinen, ...
PLoS Neglected Tropical Diseases 15 (6), e0009533, 2021
62021
Removing siloxanes and hydrogen sulfide from landfill gases with biochar and activated carbon filters
M Selenius, J Ruokolainen, J Riikonen, J Rantanen, S Näkki, VP Lehto, ...
Waste Management 167, 31-38, 2023
12023
Biocompatibility improvement of mesoporous silicon by PEGylation
S Näkki
Itä-Suomen yliopisto, 2013
12013
In-111-radiolabeling of tri-PEGylated porous silicon nanoparticles and their in vivo evaluation in murine 4T1 breast cancer model
D Lumen, S Nakki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ...
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 62, S377-S378, 2019
2019
Functionalization of porous silicon nanovectors for targeted cancer therapy
S Näkki
Itä-Suomen yliopisto, 2018
2018
King’s Research Portal
S Näkki, J Wang, J Wu, L Fan, J Rantanen, T Nissinen, W Xu
2018
Supplementary Materials: Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
D Lumen, S Näkki, S Imlimthan, E Lambidis, M Sarparanta, W Xu, ...
Improved Circulation Time of Imageable Mesoporous Silicon Nanocarrier
VP Lehto, S Näkki, T Nissinen, J Riikonen, H Santos, H Zhang, ...
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–16